The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Abroskina M.V.

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University;
Regional Clinical Hospital

Khomchenkova A.A.

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University;
Regional Clinical Hospital

Kazadaeva I.A.

Regional Clinical Hospital

Dadeko D.A.

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Clinical and demographic features of multiple sclerosis in the Krasnoyarsk Krai

Authors:

Abroskina M.V., Khomchenkova A.A., Kazadaeva I.A., Dadeko D.A.

More about the authors

Read: 392 times


To cite this article:

Abroskina MV, Khomchenkova AA, Kazadaeva IA, Dadeko DA. Clinical and demographic features of multiple sclerosis in the Krasnoyarsk Krai. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;126(1):120‑125. (In Russ.)
https://doi.org/10.17116/jnevro2026126011120

References:

  1. Boinova IV, Samarina DV, Katorova AV, et al. Clinical and epidemiological features of multiple sclerosis In Russian Federation. Sovremennye problemy nauki i obrazovaniya. 2022;5(4):34-38. (In Russ.). https://doi.org/10.17513/spno.32006
  2. Lashch NYu. From clinical research to practical application: stopping the activity and progression of multiple sclerosis means giving hope to the patient. Meditsinskii Sovet. 2020;8:88-94. (In Russ.). https://doi.org/10.21518/2079-701x-2020-8-88-94
  3. Boiko AN, Kukel’ TM, Lysenko MA, et al. Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow. S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113(10‐2):8‐14. (In Russ.).
  4. Boiko AN, Gusev EI. Current algorithms of diagnosis and treatment of multiple sclerosis based on the individual assessment of the patient. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(2-2):92-106. (In Russ.). https://doi.org/10.17116/jnevro20171172292-106
  5. Evdoshenko EP, Teptsova TS, Zheleznyakova IA, et al. Analiz neudovletvorennykh potrebnostei sistemy zdravookhraneniya v Rossiiskoi Federatsii. M. 2020. (In Russ.).
  6. Grigolashvili MA, Pakhomov AV, Dzhilisbaeva GS, et al. Identification of clinical and neurological syndromes, the degree of disablement and the intensity degree of functional system disorders, depending on the type of multiple sclerosis course among patients of Karaganda region. Universum: meditsina i farmakologiya: elektron. nauchn. zhurn. 2021;1(74):23-29. (In Russ.). https://7universum.com/ru/med/archive/item/11169
  7. Dorokhov AD, Shkilnyuk GG, Tsvetkova TL, et al. Features of walking disorders in multiple sclerosis. Prakticheskaya meditsina. 2019;17(7):28-32. (In Russ.). https://doi.org/10.32000/2072-1757-2019-7-28-32
  8. Walton C, King R, Rechtman L, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816-1821. https://doi.org/10.1177/1352458520970841
  9. Fetisova EK, Vorob’eva NV, Muntyan MS. Rasseyannyi skleroz. Multiple sclerosis. Some features of pathology and prospects for therapy. Part 1. Vestnik Moskovskogo universiteta. Seriya 16: Biologiya. 2024:79(2):87-101. (In Russ.). https://doi.org/10.55959/MSU0137-0952-16-79-2-2
  10. Dobson R., Giovannoni G. Multiple sclerosis — a review. Eur J Neurol. 2019;26(1):27-40.  https://doi.org/10.1111/ene.13819
  11. Bellucci G, Rinaldi V, Buscarinu MC, et al. Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? Front Immunol. 2021;12:755333. https://doi.org/10.3389/fimmu.2021.755333
  12. Tavazzi E, Pichiecchio A, Colombo E, et al. The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review. Viruses. 2023;15(7):1569. https://doi.org/10.3390/v15071569
  13. Kulbayeva ZD, Grigolashvili MA, Kaliyev SS, et al. To the issue of multiple sclerosis epidemiology. Meditsina i ekologiya. 2019;4:11-18. (In Russ.).
  14. Zhusupova AT, Kadyrova BB, Dzhaparalieva NT, et al. Analysis of the risk factors and the prevalense of multiple sclerosis (Literature review). Vestnik KRSU. 2022:22(5):121-126. (In Russ.). https://doi.org/10.36979/1694-500X-2022-22-5-121-126
  15. Arkhipov IE, Prokaeva AI, Tretyakova EV, et al. Epidemiology of multiple sclerosis in the city of Novosibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(1):119‐127. (In Russ.). https://doi.org/10.17116/jnevro2025125011119
  16. Smagina IV, Elchaninova EYu, Elchaninova SA. Multiple sclerosis in the Altai region of Russia: a prospective epidemiological study. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2-2):7-11. (In Russ.). https://doi.org/10.17116/jnevro2019119227
  17. Sivertseva SA, Prilenskaya AM, Kandala NS, et al. Current state of multiple sclerosis epidemiology in the Tyumen Region. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;8:157. (In Russ.). https://doi.org/10.17116/jnevro2018118082128
  18. Nikolaeva TN, Gorokhova NYu, Yulacheva AN, et al. Prevalence of multiple sclerosis in Yakutia. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;5:63-64. (In Russ.). https://doi.org/10.17116/jnevro201911905S

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.